Solid Malignancies clinical trials at UCSF

1 in progress, 0 open to eligible people

AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Sorry, not currently recruiting here
This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer agents in 270 patients with advanced cancer that has recurred/progressed.
San Francisco, California and other locations

Last updated: August 25, 2023

AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies